Gladstone Institutional Advisory LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Gladstone Institutional Advisory LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$131
-33.5%
53,500
+10.3%
0.01%
-43.5%
Q2 2021$197
-10.0%
48,5000.0%0.02%
-32.4%
Q1 2021$219
-13.4%
48,500
-5.8%
0.03%
-32.0%
Q4 2020$25351,5000.05%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 3,661,237$8,970,0000.44%
Alpine Global Management, LLC 370,000$907,0000.21%
DELTEC ASSET MANAGEMENT LLC 460,500$1,128,0000.17%
IHT Wealth Management, LLC 334,367$819,0000.07%
Redmile Group, LLC 1,358,825$3,329,0000.06%
GPS Wealth Strategies Group, LLC 58,025$142,0000.04%
Granahan Investment Management 465,049$1,139,0000.02%
SEARLE & CO. 20,000$49,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 402,300$986,0000.02%
Gladstone Institutional Advisory LLC 53,500$1310.01%
View complete list of XERIS PHARMACEUTICALS INC shareholders